Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
17 Sep 2024 |
AA |
Full accounts made up to 31 December 2023
|
|
|
27 Aug 2024 |
CS01 |
Confirmation statement made on 16 August 2024 with no updates
|
|
|
08 Jan 2024 |
MA |
Memorandum and Articles of Association
|
|
|
08 Jan 2024 |
RESOLUTIONS |
Resolutions
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
02 Jan 2024 |
AP01 |
Appointment of Goncalo Jose Geada De Mello Barreto as a director on 1 January 2024
|
|
|
04 Oct 2023 |
AA |
Full accounts made up to 31 December 2022
|
|
|
22 Aug 2023 |
CS01 |
Confirmation statement made on 16 August 2023 with no updates
|
|
|
03 Aug 2023 |
PSC08 |
Notification of a person with significant control statement
|
|
|
03 Aug 2023 |
PSC07 |
Cessation of Montserrat Esteve Soler as a person with significant control on 10 July 2023
|
|
|
25 Aug 2022 |
CS01 |
Confirmation statement made on 16 August 2022 with updates
|
|
|
19 May 2022 |
AA |
Full accounts made up to 31 December 2021
|
|
|
16 Nov 2021 |
AD01 |
Registered office address changed from The Granary, the Courtyard Barns Choke Lane Cookham Dean Maidenhead Berkshire SL6 6PT England to The Round House, the Courtyard Barns Choke Lane Cookham Dean Maidenhead Berkshire SL6 6PT on 16 November 2021
|
|
|
15 Nov 2021 |
CERTNM |
Company name changed intrapharm laboratories LIMITED\certificate issued on 15/11/21
-
NM01 ‐
Change of name by resolution
-
RES15 ‐
Change company name resolution on 2021-11-15
|
|
|
19 Oct 2021 |
SH19 |
Statement of capital on 19 October 2021
|
|
|
19 Oct 2021 |
SH20 |
Statement by Directors
|
|
|
19 Oct 2021 |
CAP-SS |
Solvency Statement dated 18/10/21
|
|
|
19 Oct 2021 |
RESOLUTIONS |
Resolutions
-
RES13 ‐
Reduction of share premuim account 18/10/2021
-
RES06 ‐
Resolution of reduction in issued share capital
|
|
|
01 Oct 2021 |
AA |
Full accounts made up to 31 December 2020
|
|
|
24 Sep 2021 |
CS01 |
Confirmation statement made on 16 August 2021 with updates
|
|
|
21 Jul 2021 |
SH01 |
Statement of capital following an allotment of shares on 1 July 2021
|
|
|
07 Jul 2021 |
PSC01 |
Notification of Montserrat Esteve Soler as a person with significant control on 1 July 2021
|
|
|
07 Jul 2021 |
PSC07 |
Cessation of Riemser Pharma Uk Limited as a person with significant control on 1 July 2021
|
|
|
13 May 2021 |
MR04 |
Satisfaction of charge 033936860004 in full
|
|
|
08 Feb 2021 |
AA |
Full accounts made up to 31 December 2019
|
|
|
18 Nov 2020 |
TM01 |
Termination of appointment of Mohammed Choudhary Shafiq as a director on 30 September 2020
|
|